MARKETS
Markets

SciSparc Unit Neurothera Labs Receives Japanese Patent For Its Pharmacological Combination Titled 'Compositions And Methods For Potentiating Derivatives Of 4-Aminophenols'

Aug 12, 2026 · 08:26 AM ET· updated 1h ago

The newly granted Japanese patent covers pharmaceutical compositions and methods comprising proprietary combinations of 4-aminophenols derivatives (including paracetamol) and N-acylethanolamines. These combinations are

Share
Why It Matters

SciSparc's medicine unit got permission from Japan to make and sell a special mix of pain-relief ingredients. This is good because it means more countries recognize their invention, but we don't know yet if patients will actually use it.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.